Bessemer Group’s Cantel Medical Corporation CMD Stock Holding History

Bessemer Group’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-115	Closed	-$9K	–	1703
2020 Q4	$9K	Buy	+115	New	+$6.75K	﹤0.01%	1318
2020 Q3	–	Sell	-16	Closed	-$1K	–	1777
2020 Q2	$1K	Hold	16	–	–	﹤0.01%	1682
2020 Q1	$1K	Hold	16	–	–	﹤0.01%	1594
2019 Q4	$1K	Buy	+16	New	+$1.16K	﹤0.01%	1613
2018 Q3	–	Sell	-4,800	Closed	-$472K	–	1924
2018 Q2	$472K	Sell	4,800 -4,300	-47%	-$481K	﹤0.01%	785
2018 Q1	$1.01M	Sell	9,100 -3,900	-30%	-$437K	﹤0.01%	575
2017 Q4	$1.34M	Hold	13,000	–	–	0.01%	526
2017 Q3	$1.22M	Sell	13,000 -1,000	-7%	-$78.9K	﹤0.01%	596
2017 Q2	$1.09M	Hold	14,000	–	–	﹤0.01%	640
2017 Q1	$1.12M	Hold	14,000	–	–	﹤0.01%	669
2016 Q4	$1.1M	Hold	14,000	–	–	0.01%	680
2016 Q3	$1.09M	Buy	+14,000	New	+$1.02M	0.01%	589
2016 Q2	–	Sell	-110	Closed	-$8K	–	1503
2016 Q1	$8K	Buy	+110	New	+$6.91K	﹤0.01%	1177
2013 Q3	–	Sell	-1,709	Closed	-$39K	–	1410
2013 Q2	$39K	Buy	+1,709	New	+$37K	﹤0.01%	813

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Bessemer Group's CMD Position: Q1 2021 in Review

Bessemer Group sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 115 shares — an estimated $9K sold.

Bessemer Group first reported a position in CMD in Q2 2013 and held it in 14 quarters. The position peaked at $1.34M in Q4 2017. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

Bessemer Group reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
Bessemer Group sold 115 Cantel Medical Corporation shares in Q1 2021, an estimated $9K.
Bessemer Group first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 14 quarters.
Bessemer Group's Cantel Medical Corporation position peaked at $1.34M in Q4 2017.
234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Bessemer Group's 13F filing for Q1 2021, filed 13 May 2021.